Results 101 to 110 of about 754,510 (299)
Comparison of systematic and combined biopsy for the detection of prostate cancer
Asian Journal of AndrologySystematic prostate biopsy has limitations, such as overdiagnosis of clinically insignificant prostate cancer and underdiagnosis of clinically significant prostate cancer.Jin-Lun Huang, Da Huang, Tsun-Tsun Chun, Chi Yao, Yong-Le Zhan, Xiao-Hao Ruan, Terence Chun-Ting Lai, Chiu-Fung Tsang, Karl-Ho Pang, Ada Tsui-Lin Ng, Dan-Feng Xu, Brian Sze-Ho Ho, Rong Na +12 moredoaj +1 more sourceZMIZ2–DUX4–LGR5 Signaling Axis Maintains Stemness Properties and Facilitates Docetaxel Resistance in Triple‐Negative Breast Cancer
Advanced Science, EarlyView.This study identifies ZMIZ2 as a therapeutic target for docetaxel‐resistant triple‐negative breast cancer, sustaining cancer stemness‐associated properties and docetaxel resistance. ZMIZ2 upregulation enhances DUX4‐mediated LGR5 activation through the SWI/SNF components BRG1 and BAF57.Xueting Gan, Shulei Sun, Ran Hu, Yuheng Feng, Xinhao Wu, Fangqi Liu, Xuyong Lin, Xiupeng Zhang, Xuezhu Rong, Qiang Han +9 morewiley +1 more sourceMRI-targeted or standard biopsy for prostate-cancer diagnosis [PDF]
, 2018 Background Multiparametric magnetic resonance imaging (MRI), with or without targeted biopsy, is an alternative to standard transrectal ultrasonography-guided biopsy for prostate-cancer detection in men with a raised prostate-specific antigen level who ...Pinto, Peter, Punwani, Shonit, Giles Hellawell, Eggener, Scott, Francesco Giganti, Villers, Arnauld, Salvo, Vincenzo, Briganti, Alberto, Vaarala, Markku H., Shonit Punwani, Marcelo Borghi, Arnauld Villers, Hellawell, Giles, Jonathan Deeks, Inderbir Gill, Mynderse, Lance A., Franck Bladou, Lars Budäus, Hadaschik, Boris A., Veeru Kasivisvanathan, Hu, Jim C, Laurence Klotz, Crouzet, Sébastien, Takwoingi, Yemisi, Becher, Edgardo F., Sébastien Crouzet, Panebianco, Valeria, Geert M. Villeirs, Grompone, Marcello, Roobol, Monique J, Singh, Paras B., Kasivisvanathan, Veeru, Boris A. Hadaschik, Scott Eggener, Jaspal Virdi, Alex Freeman, Del Monte, Maurizio, Allen, Clare, Vaarala, Markku H, Roobol, Monique J., Williams, Norman R., Mark Emberton, Hadaschik, Boris A, Peter Pinto, Silvan Boxler, Caroline M. Moore, Costantino, Leonardo, Alain Ruffion, Yemisi Takwoingi, Monique J. Roobol, Lance A. Mynderse, Stephen Morris, Wulphert Venderink, Valeria Panebianco, Margolis, Daniel, Antti S. Rannikko, Borghi, Marcelo, Rannikko, Antti S., Ruffion, Alain, Villeirs, Geert, Markku H. Vaarala, Mynderse, Lance A, Emberton, Mark, Virdi, Jaspal, Hindley, Richard G, Sciarra, Alessandro, Giganti, Francesco, Morris, Stephen, Campa, Riccardo, Kenttämies, Anu, Gill, Inderbir, Moore, Caroline M., Williams, Norman R, Taneja, Samir S., Taneja, Samir S, Venderink, Wulphert, Ghei, Maneesh, Paras B. Singh, Klotz, Laurence, PRECISION Study Group Collaborators, Singh, Paras B, Robert, Grégoire, Catalano, Carlo, Hindley, Richard G., Grompone, Marcello Domenico, Chris Brew-Graves, Brew-Graves, Chris, Rannikko, Antti S, Samir S. Taneja, Villeirs, Geert M, Budäus, Lars, Moore, Caroline M, Boxler, Silvan, Mirtti, Tuomas, Deeks, Jonathan, D'Eramo, Giuseppe, Villeirs, Geert M., Daniel Margolis, Maneesh Ghei, Bladou, Franck, Richard G. Hindley, Clare Allen, Hu, Jim C., Norman R. Williams, Jim C. Hu, PRECISION, Study Group Collaborators, Grégoire Robert, Freeman, Alex, Alberto Briganti, Moore, C.M., Giganti, F., Williams, N.R., Mynderse LA, Rannikko, AS, Panebianco, V, Hellawell G, Kasivisvanathan V, Briganti, A., Crouzet, S., Margolis D, Giganti F, Deeks J, Roobol MJ, Roobol, M.J., Ruffion A, Deeks, J., Eggener, S, Gill, I., Boxler, S, Witjes, W.P., Hindley, RG, Allen, C., Mynderse, L.A., Kasivisvanathan, V, Virdi, J, Budaus, L, Bladou F, Mulders, P.F.A., Klotz, L., Rannikko, A.S., Allen, C, Gill I, Crouzet, S, Borghi, M., Kasivisvanathan, V., Villeirs, G.M., Deeks, J, Brew-Graves, C., Emberton, M., Panebianco, V., Eggener S, Budäus, L., Vaarala MH, Panebianco V, Fütterer, J.J., Ghei, M, Moore CM, Villers, A, Pinto, P., Morris S, Roobol - Bouts, Monique, Budäus L, Hu, J.C., Klotz, L, Taneja, S.S., Giganti, F, Robert, G., Hadaschik, B.A., Borghi, M, Venderink, W., Hindley, R.G., Punwani, S., Hindley RG, Morris, S., Virdi, J., Brew-Graves, C, Rannikko AS, Freeman, A., Ruffion, A., Brembilla, Giorgio, Emberton, M, Virdi J, Borghi M, Takwoingi, Y., Singh, P.B., Vaarala, M.H., Hu JC, Briganti A, Vaarala, MH, Venderink W, Hu, JC, Gill, I, Lund University., Villeirs GM, Hellawell, G, Ghei M, Emberton M, Klotz L, Taneja, SS, Bladou, F, Taneja SS, Brew-Graves C, Villers, A., Allen C, Singh, PB, Pinto P, Briganti, A, Hellawell, G., Hadaschik, BA, Moore, CM, Boxler S, Venderink, W, Crouzet S, Eggener, S., Margolis, D., Mynderse, LA, Bladou, F., Freeman A, Robert G, Pinto, P, Takwoingi, Y, Boxler, S., Ruffion, A, Villeirs, GM, Singh PB, Villers A, Williams, NR, Hadaschik BA, Ghei, M., Margolis, D, Williams NR, Morris, S, Punwani, S, Punwani S, Takwoingi Y, Robert, G, Freeman, A +236 morecore +2 more sourcesThe VCPIP1‐UBE3A Deubiquitination‐Ubiquitination Cascade Contributes to Castration‐Resistant Prostate Cancer Progression
Advanced Science, EarlyView.VCIPIP1 emerges as a molecular link between protein stability and prostate cancer progression. By deubiquitinating and stabilizing UBE3A, VCIPIP1 promotes p53 degradation and progression to castration‐resistant prostate cancer. Elevated VCIPIP1 expression is associated with shorter castration‐resistant prostate cancer–free survival, highlighting the ...Fei Lin, Wen‐Cai Zheng, Yi‐Qiu Wang, Bin Lin, Yun‐Zhi Lin, Dong‐Ning Chen, Xiao‐Dong Li, Xue‐Yi Xue, Yong Wei, Ning Xu +9 morewiley +1 more sourceNon‐Invasive Assessment of Perineural Invasion Density: A Novel Marker for Prognosis and Treatment Stratification in Prostate Cancer
Advanced Science, EarlyView.This study establishes perineural invasion density (PNID) as a superior prognostic marker in prostate cancer, outperforming conventional perineural invasion in predicting biochemical recurrence and radiographic progression. Concurrent β–blocker use is associated with favorable outcomes exclusively in High–PNID patients. An MRI–based deep learning model Bohao Liu, Long Zhang, Weian Zhu, Meng Yang, Xiang Liu, Xiaoyang Li, Peng Qin, Zhengxu Lin, Qian Cai, Jiayu Zheng, Xiao Zhao, Chen Zou, Xuan Wen, Longhao Xu, Daqin Wu, Lin Zhang, Cuilian Zhang, Kaiwen Li, Chunhui Wang, Wenlong Zhong, Yun Luo +20 morewiley +1 more sourceSuitability of PSA-detected localised prostate cancers for focal therapy: Experience from the ProtecT study [PDF]
, 2011 This article is available through a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. Copyright @ 2011 Cancer Research UK.Background: Contemporary screening for prostate cancer frequently identifies small volume, low-grade ...Catto, J. W. F., Rosario, D. J., J D Oxley, Donovan, J. L., Varma, M, Hamdy, F. C., M Varma, Mayer, NJ, Varma, M., Griffiths, D. F., J A Lane, Albertsen, PC, M Davis, N J Mayer, N S Deshmukh, J R Goepel, Metcalfe, C., D J Rosario, Mayer, N. J., Neal, D. E., D E Neal, M F Abbod, J W F Catto, Robinson, M. C., Robinson, MC, Goepel, JR, null null, Warren, A. Y., Griffiths, DF, A Y Warren, ProtecT Study Grp, P. S. G., Hamdy, FC, Davis, MJ, Catto, JW, Donovan, JL, Lane, J. A., Oxley, JD, Deshmukh, NS, Goepel, J. R., K M Grigor, Rosario, DJ, Neal, DE, M C Robinson, F C Hamdy, Deshmukh, N. S., Warren, AY, Albertsen, P. C., Abbod, MF, P C Albertsen, Lane, JA, J L Donovan, Oxley, J. D., Grigor, K. M., C Metcalfe, Davis, M., D A Linkens, Davis, M, Catto, JWF, Metcalfe, C, Linkens, D. A., Grigor, KM, Abbod, M. F., D F Griffiths, Linkens, DA +63 morecore +1 more sourceDTX3 Suppresses the NPM3–RUVBL1 Axis to Inhibit Homologous Recombination Repair and Abrogate Tumor Radioresistance
Advanced Science, EarlyView.Deltex 3 (DTX3) catalyzes K27‐linked ubiquitination of nucleophosmin 3 to disrupt homologous recombination repair and reverse tumor radioresistance. Low DTX3 predicts poor survival and radiotherapy recurrence, serving as a radiosensitizing therapeutic target.Jia‐Hao Xiao, Chang‐Jun Xie, Yan‐Hua Chen, Hao Cheng, Shuang‐Hui Li, Wei Li, Ya‐Wen Bin, Rui‐Min He, Ying‐Qing Li, Ping Feng +9 morewiley +1 more sourceAI‐Driven Cancer Multi‐Omics: A Review From the Data Pipeline Perspective
Advanced Intelligent Discovery, EarlyView.The exponential growth of cancer multi‐omics data brings opportunities and challenges for precision oncology. This review systematically examines AI's role in addressing these challenges, covering generative models, integration architectures, Explainable AI for clinical trust, clinical applications, and key directions for clinical translation.Shilong Liu, Shunxiang Li, Kun Qianwiley +1 more source